Targeting of aberrant αvβ6 integrin expression in solid tumors using chimeric antigen receptor-engineered T cells

LM Whilding, AC Parente-Pereira, T Zabinski… - Molecular Therapy, 2017 - cell.com
Expression of the αvβ6 integrin is upregulated in several solid tumors. In contrast,
physiologic expression of this epithelial-specific integrin is restricted to development and …

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

LM Whilding, S Vallath, J Maher - Biochemical Society …, 2016 - portlandpress.com
Immunotherapy of cancer using chimeric antigen receptor (CAR) T-cells is a rapidly
expanding field. CARs are fusion molecules that couple the binding of a tumour-associated …

CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models

L Wallstabe, A Mades, S Frenz… - Advances in cell and …, 2018 - Wiley Online Library
Integrins are heterodimeric receptors that convey cell‐to‐cell and cell‐to‐matrix interactions.
Integrin αvβ3 is expressed in several tumor entities including melanoma, glioblastoma …

[HTML][HTML] Chimeric antigen receptor T cells targeting integrin αvβ6 expressed on cholangiocarcinoma cells

N Phanthaphol, C Somboonpatarakun… - Frontiers in …, 2021 - frontiersin.org
Cholangiocarcinoma (CCA) is a lethal bile duct cancer that responds poorly to current
standard treatments. A new therapeutic approach is, therefore, urgently needed. Adoptive T …

[PDF][PDF] Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

E Dodagatta-Marri, HY Ma, B Liang, J Li, DS Meyer… - Cell reports, 2021 - cell.com
Summary αvβ8 integrin, a key activator of transforming growth factor β (TGF-β), inhibits anti-
tumor immunity. We show that a potent blocking monoclonal antibody against αvβ8 (ADWA …

[HTML][HTML] Targeting of the alphav beta3 integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma

DA Cobb, J de Rossi, L Liu, E An… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Diffuse intrinsic pontine glioma (DIPG) and glioblastoma (GBM) are two highly
aggressive and generally incurable gliomas with little therapeutic advancements made in …

In vivo retargeting of adenovirus type 5 to αvβ6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery

L Coughlan, S Vallath, A Saha, M Flak… - Journal of …, 2009 - Am Soc Microbiol
ABSTRACT A key impediment to successful cancer therapy with adenoviral vectors is the
inefficient transduction of malignant tissue in vivo. Compounding this problem is the lack of …

Integrin αvβ3‐targeted cancer therapy

Z Liu, F Wang, X Chen - Drug development research, 2008 - Wiley Online Library
Anti‐angiogenesis is a promising strategy for the treatment of cancer. Integrins, consisting of
two noncovalently bound transmembrane α and β subunits, are an important molecular …

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

C Eberlein, J Kendrew, K McDaid, A Alfred, JS Kang… - Oncogene, 2013 - nature.com
Abstract αvβ6 integrin expression is upregulated on a wide range of epithelial tumours, and
is thought to play a role in modulating tumour growth. Here we describe a human …

Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation

A Capsomidis, G Benthall, HH Van Acker, J Fisher… - Molecular Therapy, 2018 - cell.com
Gamma delta T (γδT) lymphocytes are primed for rapid function, including cytotoxicity toward
cancer cells, and are a component of the immediate stress response. Following activation …